Judit Váradi

2.4k total citations
74 papers, 1.8k citations indexed

About

Judit Váradi is a scholar working on Molecular Biology, Pharmaceutical Science and Biomaterials. According to data from OpenAlex, Judit Váradi has authored 74 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 23 papers in Pharmaceutical Science and 12 papers in Biomaterials. Recurrent topics in Judit Váradi's work include Drug Solubulity and Delivery Systems (16 papers), Advanced Drug Delivery Systems (11 papers) and Nanoparticle-Based Drug Delivery (10 papers). Judit Váradi is often cited by papers focused on Drug Solubulity and Delivery Systems (16 papers), Advanced Drug Delivery Systems (11 papers) and Nanoparticle-Based Drug Delivery (10 papers). Judit Váradi collaborates with scholars based in Hungary, Romania and United Kingdom. Judit Váradi's co-authors include Ferenc Fenyvesi, Miklós Vecsernyés, Ildikó Bácskay, Pálma Fehér, Zoltán Ujhelyi, Gábor Vasvári, Tímea Kiss, Éva Fenyvesi, Lajos Szente and Árpád Tósaki and has published in prestigious journals such as Immunity, PLoS ONE and The FASEB Journal.

In The Last Decade

Judit Váradi

71 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Judit Váradi Hungary 24 536 530 253 200 159 74 1.8k
Abeer Salama Egypt 30 625 1.2× 617 1.2× 248 1.0× 210 1.1× 235 1.5× 165 2.8k
Ildikó Bácskay Hungary 28 660 1.2× 669 1.3× 309 1.2× 224 1.1× 230 1.4× 119 2.3k
Ferenc Fenyvesi Hungary 26 665 1.2× 649 1.2× 336 1.3× 237 1.2× 181 1.1× 100 2.2k
Yuan Zhu China 25 482 0.9× 466 0.9× 299 1.2× 135 0.7× 219 1.4× 57 1.7k
Jaehwi Lee South Korea 22 804 1.5× 481 0.9× 231 0.9× 161 0.8× 212 1.3× 38 2.2k
Weifeng Zhu China 28 738 1.4× 393 0.7× 226 0.9× 114 0.6× 264 1.7× 124 2.2k
Mohammad Hadi Nematollahi Iran 29 752 1.4× 287 0.5× 272 1.1× 212 1.1× 189 1.2× 96 2.4k
Osama A. A. Ahmed Saudi Arabia 28 551 1.0× 906 1.7× 299 1.2× 144 0.7× 168 1.1× 111 2.1k
Aihua Yu China 21 412 0.8× 681 1.3× 398 1.6× 150 0.8× 262 1.6× 36 1.6k
Souad Sfar Tunisia 12 455 0.8× 327 0.6× 298 1.2× 94 0.5× 209 1.3× 35 1.4k

Countries citing papers authored by Judit Váradi

Since Specialization
Citations

This map shows the geographic impact of Judit Váradi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judit Váradi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judit Váradi more than expected).

Fields of papers citing papers by Judit Váradi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judit Váradi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judit Váradi. The network helps show where Judit Váradi may publish in the future.

Co-authorship network of co-authors of Judit Váradi

This figure shows the co-authorship network connecting the top 25 collaborators of Judit Váradi. A scholar is included among the top collaborators of Judit Váradi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judit Váradi. Judit Váradi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hermenean, Anca, A. Hamilton, Maria Consiglia Trotta, et al.. (2024). Chrysin Directing an Enhanced Solubility through the Formation of a Supramolecular Cyclodextrin–Calixarene Drug Delivery System: A Potential Strategy in Antifibrotic Diabetes Therapeutics. Pharmaceuticals. 17(1). 107–107. 6 indexed citations
3.
4.
Olàh, Boglàrka, et al.. (2023). Effectiveness of Anthocyanin-Rich Sour Cherry Extract on Gliadin-Induced Caco-2 Barrier Damage. Nutrients. 15(18). 4022–4022. 6 indexed citations
5.
Fenyvesi, Ferenc, et al.. (2023). First Synthesis of DBU-Conjugated Cationic Carbohydrate Derivatives and Investigation of Their Antibacterial and Antifungal Activity. International Journal of Molecular Sciences. 24(4). 3550–3550. 3 indexed citations
6.
Vasvári, Gábor, Dániel Nemes, Zoltán Ujhelyi, et al.. (2022). Enhanced Antioxidant and Anti-Inflammatory Effects of Self-Nano and Microemulsifying Drug Delivery Systems Containing Curcumin. Molecules. 27(19). 6652–6652. 23 indexed citations
7.
Haimhoffer, Ádám, Gábor Vasvári, István Budai, et al.. (2022). In Vitro and In Vivo Studies of a Verapamil-Containing Gastroretentive Solid Foam Capsule. Pharmaceutics. 14(2). 350–350. 8 indexed citations
8.
Kovács, Renátó, Ferenc Fenyvesi, György Vámosi, et al.. (2022). Concentration-Dependent Antibacterial Activity of Chitosan on Lactobacillus plantarum. Pharmaceutics. 15(1). 18–18. 14 indexed citations
9.
Rusznyák, Ágnes, Milo Malanga, Éva Fenyvesi, et al.. (2022). Cellular Effects of Cyclodextrins: Studies on HeLa Cells. Molecules. 27(5). 1589–1589. 9 indexed citations
10.
Haimhoffer, Ádám, Dániel Nemes, Pálma Fehér, et al.. (2022). Topical Dosage Formulation of Lyophilized Philadelphus coronarius L. Leaf and Flower: Antimicrobial, Antioxidant and Anti-Inflammatory Assessment of the Plant. Molecules. 27(9). 2652–2652. 5 indexed citations
11.
Haimhoffer, Ádám, Éva Fenyvesi, László Jicsinszky, et al.. (2022). Investigation of the Drug Carrier Properties of Insoluble Cyclodextrin Polymer Microspheres. Biomolecules. 12(7). 931–931. 6 indexed citations
12.
Remenyik, Judit, Attila Bíró, Gábor Vasvári, et al.. (2022). Comparison of the Modulating Effect of Anthocyanin-Rich Sour Cherry Extract on Occludin and ZO-1 on Caco-2 and HUVEC Cultures. International Journal of Molecular Sciences. 23(16). 9036–9036. 11 indexed citations
13.
Trotta, Maria Consiglia, Francesco Petrillo, Carlo Gesualdo, et al.. (2022). Effects of the Calix[4]arene Derivative Compound OTX008 on High Glucose-Stimulated ARPE-19 Cells: Focus on Galectin-1/TGF-β/EMT Pathway. Molecules. 27(15). 4785–4785. 8 indexed citations
14.
Czimmerer, Zsolt, László Halász, Bence Dániel, et al.. (2022). The epigenetic state of IL-4-polarized macrophages enables inflammatory cistromic expansion and extended synergistic response to TLR ligands. Immunity. 55(11). 2006–2026.e6. 39 indexed citations
15.
Fenyvesi, Ferenc, Judit Váradi, Miklós Vecsernyés, et al.. (2021). Formulation of Novel Liquid Crystal (LC) Formulations with Skin-Permeation-Enhancing Abilities of Plantago lanceolata (PL) Extract and Their Assessment on HaCaT Cells. Molecules. 26(4). 1023–1023. 9 indexed citations
16.
Rusznyák, Ágnes, Milo Malanga, Éva Fenyvesi, et al.. (2021). Investigation of the Cellular Effects of Beta- Cyclodextrin Derivatives on Caco-2 Intestinal Epithelial Cells. Pharmaceutics. 13(2). 157–157. 12 indexed citations
17.
Fenyvesi, Ferenc, Judit Váradi, Miklós Vecsernyés, et al.. (2021). Oral Bioavailability Enhancement of Melanin Concentrating Hormone, Development and In Vitro Pharmaceutical Assessment of Novel Delivery Systems. Pharmaceutics. 14(1). 9–9. 5 indexed citations
18.
Fenyvesi, Ferenc, Ádám Haimhoffer, Ágnes Rusznyák, et al.. (2020). Cyclodextrin Complexation Improves the Solubility and Caco-2 Permeability of Chrysin. Materials. 13(16). 3618–3618. 56 indexed citations
19.
Papp, Ildikó, János Elek, Géza Regdon, et al.. (2020). In Vitro Tests of FDM 3D-Printed Diclofenac Sodium-Containing Implants. Molecules. 25(24). 5889–5889. 17 indexed citations
20.
Perret, Florent, Beomjoon Kim, Renátó Kovács, et al.. (2019). Fused Deposition Modeling 3D Printing: Test Platforms for Evaluating Post-Fabrication Chemical Modifications and In-Vitro Biological Properties. Pharmaceutics. 11(6). 277–277. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Abeer Salama Breakdown of academic impact, for papers by Ildikó Bácskay Breakdown of academic impact, for papers by Ferenc Fenyvesi Breakdown of academic impact, for papers by Yuan Zhu Breakdown of academic impact, for papers by Jaehwi Lee Breakdown of academic impact, for papers by Weifeng Zhu Breakdown of academic impact, for papers by Mohammad Hadi Nematollahi Breakdown of academic impact, for papers by Osama A. A. Ahmed Breakdown of academic impact, for papers by Aihua Yu Breakdown of academic impact, for papers by Souad Sfar
Rankless by CCL
2026